Estimate Recalculated Jun 10, 2025 09:31PM EST
Sven Ante Lundberg has an estimated net worth of $24.4 Million. This is based on reported shares across multiple companies, which include Merus N.V., Vor Biopharma Inc., CRISPR Therapeutics AG, and Homology Medicines, Inc..
Sven Ante Lundberg's CIK is 0001682126
2021 was Sven Ante Lundberg's most active year for acquiring shares with 6 total transactions. Sven Ante Lundberg's most active month to acquire stocks was the month of July. 2021 was Sven Ante Lundberg's most active year for disposing of shares, totalling 5 transactions. Sven Ante Lundberg's most active month to dispose stocks was the month of February. 2021 saw Sven Ante Lundberg paying a total of $1,190,341.06 for 473,900 shares, this is the most they've acquired in one year. In 2021 Sven Ante Lundberg cashed out on 163,000 shares for a total of $200,474.46, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!